We are live on ! Find out more
APTO

Aptose Biosciences

Delisted

APTO was delisted on the 1st of April, 2025.

16 hedge funds and large institutions have $1.52M invested in Aptose Biosciences in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more capital inflows, than outflows

Capital inflows: $878K | Capital outflows: $453K

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

7% more funds holding

Funds holding: 15 → 16 (+1)

0.2% more ownership

Funds ownership: 1.36% → 1.56% (+0.2%)

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

Holders
16
Holders Change
+1
Holders Change %
+6.67%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

APTO Hedge Fund Activity: Q1 2018 in Review

16 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Aptose Biosciences (APTO) for Q1 2018, worth a combined $1.52M — up 85% from $819K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new APTO positions and 4 closed out — a net gain of 1 holder — while 2 added to existing stakes and 5 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $357K. The largest seller was Acadian Asset Management, cutting an estimated $107K.

  • 16 institutional investors held Aptose Biosciences (APTO) as of Q1 2018, up from 15 in Q4 2017.
  • Funds reported $1.52M of Aptose Biosciences stock for Q1 2018, up 85% quarter-over-quarter.
  • 5 funds opened new Aptose Biosciences positions in Q1 2018 and 4 closed out, a net change of +1 holder.
  • The largest Aptose Biosciences buyer in Q1 2018 was Morgan Stanley, an estimated $357K added.
  • The largest Aptose Biosciences seller in Q1 2018 was Acadian Asset Management, an estimated $107K sold.

Based on aggregated 13F filings for Q1 2018.